Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15-25: a randomized, double-blind, phase III, noninferiority clinical trial.
Eur J Cancer Prev. 2022 Nov 1;31(6):558-567. doi: 10.1097/CEJ.0000000000000753. Epub 2022 Mar 29.
Eur J Cancer Prev. 2022.
PMID: 35352698
Clinical Trial.
Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate-to-severe glabellar lines: A non-inferiority double blinded randomized controlled trial.
Afshani SM, Samadi A, Ayatollahi A, Kashani MN, Ahmad Nasdrollahi S, Hosseini H, Rezagholi Z, Hedayatjoo B, Hazegh Fetratjoo D, Ghobadi MA, Anari A, Saeedifar S, Firooz A.
Afshani SM, et al.
J Cosmet Dermatol. 2022 Jun;21(6):2398-2406. doi: 10.1111/jocd.14939. Epub 2022 Apr 9.
J Cosmet Dermatol. 2022.
PMID: 35340107
Clinical Trial.
Item in Clipboard
Cite
Cite